Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx

Pathology Research and Practice

Volumn 200, Issue 3, 2004, Pages 181-188

  Şengiz, Selma ^a   Pabuççuoǧlu, Uǧur ^b   Sarioǧlu, Sülen ^b  

^a Gölcük State Hospital   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

CD34; Ki 67; Larynx; p53; Preneoplastic lesion

Indexed keywords

BIOTIN; CD34 ANTIGEN; KI 67 ANTIGEN; PROTEIN ANTIBODY; PROTEIN P53; STREPTAVIDIN; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; EPITHELIUM HYPERPLASIA; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTERMETHOD COMPARISON; KRUSKAL WALLIS TEST; LARYNGEAL BIOPSY; LARYNX CANCER; LARYNX MUCOSA; MAJOR CLINICAL STUDY; MALE; PRECANCER; PROTEIN EXPRESSION; RANK SUM TEST; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

EID: 3242655717     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2003.11.002     Document Type: Article

References (48)

1. Blackwell K.E. Fu Y.S. Calcaterra T.C. Laryngeal dysplasia, A clinicopathologic study Cancer 75 1995 457-463
2. Bosman F.T. Dysplasia classification: pathology in disgrace? J. Pathol. 194 2001 143-144
3. Brachman D.G. Molecular biology of head and neck cancer Semin. Oncol. 21 3 1994 320-329
4. Brown D.C. Gatter K.C. Monoclonal antibody Ki-67: its use in histopathology Histopathology 17 1990 489-503
5. Burkhardt A. Morphological assessment of malignant potential of epithelial hyperplastic lesions Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 12-16
6. Chomette G. Auriol M. Tranbaloc P. Blondon J. Neoplasie intraepitheliale du col uterin et angiogenese: etude morphologique Arch. Anat. Cytol. Path 37 1989 73-79
7. Craft P.S. Harris A.L. Clinical prognostic significance of tumour angiogenesis Ann. Oncology 5 1994 305-311
8. Cupic H. Kruslin B. Belicza M. Epithelial hyperplastic lesions of the larynx in biopsy specimens Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 103-104
9. Denhart B.C. Guidi A.J. Tognazzi K. Dvorak H.F. Brown L.F. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia Lab Invest. 77 6 1997 659-664
10. Dolcetti R. Doglioni C. Maestro R. Gasparotto D. Barzan L. Pastore A. Romanelli M. Boiocchi M. P53 expression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications Int. J. Cancer 52 1992 178-182
11. El-Naggar A. Lai S. Luna M.A. Sequential p53 mutation analysis of preinvasive and invasive head and neck squamous carcinoma Int. J. Cancer 64 1995 196-201
12. Fiorella R. Di Nicola V. Resta L. Epidemiological and clinical relief on hyperplastic lesions of the larynx Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 77-81
13. Folkman J. Role of angiogenesis in tumor growth and metastasis Semin. Oncol. 29 6 2002 15-18
14. Franchi A. Gallo O. Paglierani M. Sardi I. Magnelli L. Masini E. Santucci M. Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis Head Neck 24 2002 16-23
15. Gale N. Zidar N. Kambic V. Poljak M. Cör A. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 105-110
16. Gale N. Zidar N. Fischinger J. Kambic V. Clinical applicability of the Ljubljana classification of epithelial hyperplastic laryngeal lesions Clin. Otolaryngol. 25 2000 227-232
17. Gallo O. Franchi A. Chiarelli I. Porfirio B. Grande A. Simonetti L. Boccolini C. Fini-Storchi O. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 30-38
18. Gorgoulis V. Rassidakis G. Karameris A. Giatromalonaki A. Barbatis C. Kittas C. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings Virchows. Archiv. 425 1994 481-489
19. Gould V.E. Wagner B.M. Angiogenesis: an expanding universe Hum. Pathol. 33 11 2002 1061-1063
20. Greenblatt M.S. Bennett W.P. Hollstein M. Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res. 54 18 1994 4855-4878
21. Heimburg S. Oehler M.K. Kristen P. Papadopulos T. Caffier H. The endothelial marker CD34 in the assessment of tumour vascularization in ovarian cancer Anticancer Res. 17 1997 3149-3152
22. Heimburg S. Oehler M.K. Papadopulos T. Caffier H. Kristen P. Dietl J. Prognostic relevance of the endothelial marker CD34 in ovarian cancer Anticancer Res. 19 1999 2527-2530
23. Helliwell T.R. Risky epithelium in the larynx-a practical diagnosis? Histopathology 34 1999 262-265
24. Hellquist H. Lundgren J. Olofsson J. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords: a follow-up study Clin. Otolaryngol. 7 1982 11-27
25. Hellquist H. Cardesa A. Gale N. Kambic V. Michaels L. Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the working group on epithelial hyperplastic laryngeal lesions of the European Society of Pathology Histopathology 34 1999 226-233
26. Hojslet P. Nielsen V.M. Palvio D. Premalignant lesions of the larynx Acta. Otolaryngol. (Stockh.) 107 1989 150-155
27. Izawa H. Yonemitsu N. Shin T. Sugihara H. Histopathological analysis of apoptosis and expression of p53, bcl-2, bax and Ki-67 in laryngeal squamous cell carcinoma and dysplasia Auris. Nasus. Larynx 26 1999 317-330
28. Kambic V. Epithelial hyperplastic lesions-A challenging topic in laryngology Acta. Otolaryngol. (Stockh.) Suppl. 527 1997-7 11
29. Krecicki T. Jelen M. Krecicka M.Z. Szkedlarek T. Sjawoski K. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx Cancer Lett. 143 1999 23-28
30. Kropveld A. Slootweg P.J. Blankestein M.A. Terhaard C.H.J. Hordijk G.H. Ki-67 and p53 in T2 laryngeal cancer Laryngoscope 108 1998 1548-1552
31. Lindmark G. Gerdin B. Sundberg C. Pahlman L. Bergström R. Glimelius B. Prognostic significance of the microvascular count in colorectal cancer J. Clin. Oncol. 14 2 1996 461-466
32. Nadal A. Campo E. Pinto J. Mallofre C. Palacin A. Arias C. Trassera J. Cardesa A. P53 expression in normal, dysplastic and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors J. Pathol. 175 2 1995 181-188
33. Nadal A. Cardesa A. Molecular biology of laryngeal squamous cell carcinoma Virchows. Arch. 442 2003 1-7
34. Nathan C.A.O. Franklin S. Abreo F.W. Nassar R. Benedetti A. Williams J. Stucker F.J. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis Laryngoscope 109 1999 1253-1258
35. Pavelic Z.P. Gluckman J.L. The role of p53 tumor suppressor gene in human head and neck tumorigenesis Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 21-24
36. Pignataro L. Capaccio P. Pruneri G. Carboni N. Buffa R. Neri A. Ottaviani A. The predictive value of p53, MDM-2, cyclin D1 and Ki-67 in the progression from low-grade dysplasia towards carcinoma of the larynx J. Laryngol. Otol. 112 1998 455-459
37. Poljak M. Gale N. Kambic V. Ferluga D. Fischainger J. Overexpression of p53 protein in benign and malignant laryngeal epithelial lesions Anticancer. Res. 16 1996 1947-1952
38. Ravazoula P. Zolota V. Hatijicondi O. Sakellaropoulos G. Kourounis G. Maragoudakis M.E. Assessment of angiogenesis in human cervical lesions Anticancer. Res. 16 1996 3861-3864
39. Resta L. Marsigliante S. Leo G. Fiorella R. Di Nicola V. Maiorano E. Molecular biopathology of metaplastic, dysplastic, and neoplastic laryngeal epithelium Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 39-42
40. Sarioglu S. Özer E. Kirimca F. Sis B. Pabuççuoglu U. Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions Pathol. Res. Pract. 197 2001 483-486
41. Shanmugaratnam K. Sobin L.H. The World Health Organization histological classification of tumours of the upper respiratory tract and ear. a commentary on the second edition Cancer 71 1993 2689-2697
42. Shin D.M. Kim J. Ro J.Y. Hittelman J. Roth J.A. Hong W.K. Hittelman W.N. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis Cancer Res. 54 1994 321-326
43. Sillman F. Boyce J. Fruchter R. The significance of atypical vessels and neovascularization in cervical neoplasia Am. J. Obstet. Gynecol. 139 1981 154-159
44. Silvestri F. Bussani R. Pavletic N. Mannone T. Bosatra A. From epithelial dysplasia to squamous carcinoma of the head and neck region: evolutive and prognostic histopathological markers Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 49-51
45. Tannapfel A. Weber A. Tumor markers in squamous cell carcinoma of the head and neck: clinical effectiveness and prognostic value Eur. Arch. Otorhinolaryngol. 258 2001 83-88
46. Vodovnik A. Gale N. Kambic V. Luzar B. Correlation of histomorphological criteria used in different classifications of epithelial hyperplastic lesions of the larynx Acta. Otolaryngol. (Stockh.) Suppl. 527 1997 116-119
47. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication Semin. Diagn. Pathol. 10 4 1993 302-313
48. Zidar N. Gale N. Cör A. Kambic V. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx J. Laryngol. Otol. 110 1996 440-445